Clinical Trial: A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Recurrent High Grade Glioma
Study Type: INTERVENTIONAL
Official Title: A Phase I Study of Metronomic Temozolomide With Abexinostat (PCI-24781) for Patients With Recurrent High Grade Glioma
Brief Summary:
The goal of this clinical trial is to learn about treatment for a type of brain cancer called glioma.This clinical trial is for people with glioma who have been cancer-free for a period of time but their cancer has come back.The primary goals of this clinical trial are the following:To determine the recommended dose of PCI-24781/Abexinostat with metronomic temozolomideTo evaluate side effects associated with using PCI-24781/Abexinostat with metronomic temozolomide
Read more